Jul 3, 2024, 23:45
A four-patient trial testing a unique type of mRNA cancer vaccine – NCI
National Cancer Institute (NCI) shared a post on LinkedIn:
“Recent results from several small clinical trials have suggested it may be possible to develop an effective immunotherapy for glioblastoma. Among them are findings from a four-patient trial testing a unique type of mRNA cancer vaccine.”
Read further.
Source: NCI/LinkedIn